Parallel Advisors’s Novo Nordisk NVO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.09M Sell
44,735
-3,436
-7% -$237K 0.06% 207
2025
Q1
$3.35M Buy
48,171
+52
+0.1% +$3.61K 0.08% 183
2024
Q4
$4.14M Sell
48,119
-3,268
-6% -$281K 0.09% 162
2024
Q3
$6.12M Buy
51,387
+124
+0.2% +$14.8K 0.14% 120
2024
Q2
$7.32M Buy
51,263
+55
+0.1% +$7.85K 0.19% 97
2024
Q1
$6.58M Buy
51,208
+8,823
+21% +$1.13M 0.18% 102
2023
Q4
$4.38M Buy
42,385
+1,568
+4% +$162K 0.13% 122
2023
Q3
$3.71M Buy
40,817
+497
+1% +$45.2K 0.12% 134
2023
Q2
$3.26M Buy
40,320
+1,758
+5% +$142K 0.11% 153
2023
Q1
$3.07M Buy
38,562
+12,728
+49% +$1.01M 0.1% 159
2022
Q4
$1.75M Sell
25,834
-930
-3% -$62.9K 0.08% 175
2022
Q3
$1.33M Sell
26,764
-504
-2% -$25.1K 0.06% 196
2022
Q2
$1.52M Buy
27,268
+416
+2% +$23.2K 0.07% 176
2022
Q1
$1.51M Buy
26,852
+2,370
+10% +$133K 0.06% 207
2021
Q4
$1.37M Buy
24,482
+1,164
+5% +$65.2K 0.05% 220
2021
Q3
$1.12M Sell
23,318
-1,642
-7% -$78.8K 0.05% 242
2021
Q2
$1.05M Buy
24,960
+1,626
+7% +$68.1K 0.04% 246
2021
Q1
$787K Buy
23,334
+672
+3% +$22.7K 0.04% 268
2020
Q4
$791K Buy
22,662
+6,178
+37% +$216K 0.04% 246
2020
Q3
$572K Buy
16,484
+2,634
+19% +$91.4K 0.04% 277
2020
Q2
$453K Buy
13,850
+938
+7% +$30.7K 0.03% 315
2020
Q1
$388K Buy
12,912
+168
+1% +$5.05K 0.03% 304
2019
Q4
$369K Buy
12,744
+512
+4% +$14.8K 0.03% 351
2019
Q3
$316K Sell
12,232
-412
-3% -$10.6K 0.03% 360
2019
Q2
$323K Sell
12,644
-146
-1% -$3.73K 0.03% 323
2019
Q1
$335K Buy
12,790
+1,560
+14% +$40.9K 0.04% 290
2018
Q4
$258K Buy
11,230
+64
+0.6% +$1.47K 0.04% 309
2018
Q3
$263K Sell
11,166
-56
-0.5% -$1.32K 0.03% 320
2018
Q2
$258K Buy
11,222
+840
+8% +$19.3K 0.04% 290
2018
Q1
$256K Sell
10,382
-272
-3% -$6.71K 0.04% 277
2017
Q4
$286K Buy
10,654
+234
+2% +$6.28K 0.05% 257
2017
Q3
$259K Buy
10,420
+2,204
+27% +$54.8K 0.04% 274
2017
Q2
$174K Buy
8,216
+2,528
+44% +$53.5K 0.03% 343
2017
Q1
$117K Buy
5,688
+3,106
+120% +$63.9K 0.02% 407
2016
Q4
$46K Buy
+2,582
New +$46K 0.01% 616